Endeavor BioMedicines

Drug Discovery

Endeavor BioMedicines is a private drug discovery company. It has raised $133 million across 2 recorded rounds; the latest was a $133 million Series C in Apr 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$132.5M
Last round
Later Stage VC (Series C)
Apr 2024
Cap table — not yet on record

Endeavor BioMedicines's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Endeavor BioMedicines
  • ·34 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Frequently asked about Endeavor BioMedicines

Where does Endeavor BioMedicines's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Endeavor BioMedicines's 2 recorded funding rounds.